Why SolarCity, GW Pharmaceuticals, and MICROS Systems Are Today's 3 Best Stocks

The S&P 500 chugs higher despite negative economic data, while SolarCity, GW Pharmaceuticals, and MICROS Systems all tack on double-digit percentage gains.

Jun 17, 2014 at 5:15PM

Just when you thought that U.S. economic data was beginning to make sense, the S&P 500 (SNPINDEX:^GSPC) finds a way to inch higher despite what can only be described as two concerning data releases.


First, the Consumer Price Index for May came in with a higher-than-expected increase of 0.4%, which comes on top of the 0.3% gain in the CPI from April. This marked the biggest jump in the CPI since February, and points to higher prices across the boards for everything from gasoline to food for consumers. There's a fine line where investors tend to be satisfied with a rising CPI, and 0.1%-0.2% per month often tends to be that level. Any less and we risk deflation, which is bad for business pricing power and margins. Any more than 0.2%, and businesses risk a decline in sales if hourly earnings aren't concurrently moving higher. Keep an eye on this figure, as it's been inching up in recent months.

In addition to CPI data, investors received a double (negative) dose of data from the housing sector in May. According to the Commerce Department, housing starts for the month dipped 6.5% to a seasonally adjusted annual rate of 1,001,000, slightly below economists' expectations. Building permits told a similar story, dipping 6.4% from April, and signaling that construction activity could be waning. This is a bit worrisome with lending rates dipping back into the low 4% range. I would expect construction activity to pick up, not slow down, at these levels.

Despite this negative data, the S&P 500 still managed to tack on 4.21 points (0.22%) to close at 1,941.99. Following its first down week in quite some time, the S&P 500 has now gained in three straight sessions.


Source: FutureAtlas.com, Flickr.

Topping the charts today, and leading all individual stocks to the upside, was solar panel retailer and leasing company SolarCity (NASDAQ:SCTY), which jumped 17.6% after announcing the acquisition of Silevo for $200 million, as well as $150 million in potential earn-out milestones. As my Foolish colleague and solar sector expert Travis Hoium noted earlier today, SolarCity's ultimate goal is to install 10 GW of solar panels per year, and the Silevo acquisition gives the company the ability to expand its module manufacturing capabilities, as well as improve output and solar efficiency. While this move should prove to be accretive to SolarCity's bottom line during the very long term, it will necessitate heavy research and development spending during the coming years, which could add to SolarCity's already large losses in the coming quarters. Keep this in mind if you consider chasing the volatile SolarCity higher.

Coming in a close second behind SolarCity is GW Pharmaceuticals (NASDAQ:GWPH), a discoverer of cannabinoids from the cannabis plant that are being investigated for use in treating various diseases and disorders.

Source: GW Pharmaceuticals.

GW tacked on 16.3% after it announced initial physician reports for epidiolex, its investigational drug for treatment-resistant epilepsy in children and young adults. The results showed a mean overall reduction in seizures of 44% across all patients, with 41% of patients witnessing a 70% or greater reduction in seizures, and 15% of patients finishing the 12-week treatment course seizure-free. Furthermore, 80% of all adverse events during the trial were considered to be mild-to-moderate in nature, with no patients dropping out of the study due to these AEs.

While this is undeniably good news for GW shareholders, I'd again point out that its only approved product overseas, Sativex, which treats MS-related spasticity, has sold poorly. Also, there's no guarantee that GW will be able to gain approval in the highly profitable U.S. markets, with marijuana still classified a schedule 1 drug. And, even if its products do gain approval, convincing physicians to prescribe a marijuana-derived drug could be difficult. All of these question marks, plus GW's frothy valuation, cause me to want to keep my distance from this stock.


Source: Alan Light, Flickr.

Finally, food and service industry applications solutions provider MICROS Systems (NASDAQ:MCRS) surged 14.9% following a report from Bloomberg that software giant Oracle (NYSE:ORCL) could be prepared to make a bid of more than $5 billion for the company. Bloomberg's report cites that the two companies are in talks, but that no deal has, of yet, been reached. The move would certainly make sense for Oracle, with its hardware sales struggling, and even its cloud-computing software having difficulty gaining traction in the U.S. By purchasing MICROS, Oracle would likely see an instant EPS boost, which could get disgruntled shareholders off its back for at least a year. I'd be careful not to get too caught up in these rumors as of yet, though, but it's a developing situation worth monitoring.

These three stocks may have soared today, but keeping up with this top stock over the long run might prove impossible! 
Give us five minutes, and we'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer handpicks one stock with outstanding potential. But it's not just any run-of-the-mill company; it’s a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year, his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252%, and 1,303% during the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

The Motley Fool owns shares of, and recommends SolarCity. It also owns shares of Oracle. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers